Search

Code of Conduct

The guidelines below govern the publication of, and commentary on the EHA Hematology Hub. Please read through them before participating. 1. Abide by the rules that normally apply.

Read more

Chairs and Members

ChairProf Dr Carlo Dufour, Gaslini Children’s Research Hospital, Genova (Italy)

Co-chairProf Dr Helen Papadaki, Institution University Hospital of Heraklion, Heraklion, Crete (Greece)

SWG Executive Board members
Kim De Keersmaecker, University of Leuven (Belgium)
Francesca Fioredda, G.

Read more

Chairs and Members

Chair (2022–2025 term)Philipp Staber, Medical University Vienna (Austria)

Co-chair (2022–2025 term)Caroline Heckman, FIMM, Helsinki (Finland)

SWG Steering Committee members (2022–2025 term)
Jean-Pierre Bourquin, Universitäts-Kinderspital Zürich (Switzerland)
Kirsten Grønbæk, University of Copenhagen (Denmark)
Eva Hellström Lindberg, Karolinska Institutet, Stockholm (Sweden)
Ulrich Jäger, Medical University Vienna (Austria)
Luca Malcovati,…

Read more

Second EHA-SAH tutorial in Argentina, another success

Hematologists from South America and mainland US gathered in Argentina on September 14-15 for brain-stretching exercises on the topics of lymphoid malignancies and plasma cell dyscrasias.

Read more

Chairs and Members

ChairUwe Platzbecker, University of Leipzig, Medical Faculty, Clinic and Polyclinic for Hematology, Cellular Therapy and Hemostaseology (Germany)

Co-chairLionel Adès, Hôpital Saint-Louis Paris, Hématologie Seniors (France)

SWG Steering Committee
Pierre Fenaux, Hôpital Saint-Louis, Hématologie Seniors, Paris (France)
Arjan van de Loosdrecht, Amsterdam UMC, Hematology (The…

Read more

Joint Membership

This membership is designed for scientific researchers and physicians from multiple national societies who specialize or are interested in hematology. The main aim is to increase the cooperation in various areas and therefore strengthen hematology at the European level.

Read more

Clinical WG

Responsibilities:
Identifying the clinical data required for collection. Locating clinical trials where suitable samples will be collected or have already been collected. Involvement in the European Registry. Assessing the type of database and dataset currently available.

Read more